Evidence map›Paper›PMID 38659391›Full record

ArticleCancer medicine2024

α-Hederin induces paraptosis by targeting GPCRs to activate Ca

Xiwu Rao, Ziwen Li, Qinchang Zhang, Yueyang Lai, Jianrong Liu, Liu Li, Haibo Cheng, Weixing Shen, Dongdong Sun

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Paraptosis-A Distinct Pathway to Cell Death.International journal of molecular sciences · 2024
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiwu RaoThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.ORCID 0000-0002-7004-387X
Ziwen LiThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Qinchang ZhangThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Yueyang LaiThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Jianrong LiuDepartment of Infectious Disease, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Liu LiThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Haibo ChengThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Weixing ShenThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Dongdong SunThe First Clinical Medical College of Nanjing University of Chinese Medicine, Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, China.
Nanjing University of Chinese Medicine · CNGuangzhou University of Chinese Medicine · CN

Funding

China Postdoctoral Science foundation 2023M740860Key projects of Traditional Chinese Medicine Technology Development Plan of Jiangsu Province ZD202201National Natural Science Foundation of China 81973523National Natural Science Foundation of China 82074318National Natural Science Foundation of China 82305340National Natural Science Foundation of China 82374287The Science and Technology Development Fund, Macau SAR 0048/2023/AFJThe Science and Technology Development Fund, Macau SAR 0098/2021/A2
6 · The paper itself

Abstract

backgroundNon-apoptotic cell death is presently emerging as a potential direction to overcome the apoptosis resistance of cancer cells. In the current study, a natural plant agent α-hederin (α-hed) induces caspase-independent paraptotic modes of cell death. PURPOSE: The present study is aimed to investigate the role of α-hed induces paraptosis and the associated mechanism of it.

methodsThe cell proliferation was detected by CCK-8. The cytoplasm organelles were observed under electron microscope. Calcium (Ca

resultsα-hed exerted significant cytotoxicity against a panel of CRC cell lines by inhibiting proliferation. Besides, it induced cytoplasmic vacuolation in all CRC cells. Electron microscopy images showed the aberrant dilation of endoplasmic reticulum and mitochondria. Both mRNA and protein expressions of Alg-2 interacting proteinX (Alix), the marker of paraptosis, were inhibited by α-hed. Besides, both Swiss prediction and molecular docking showed that the structure of α-hed could tightly target to GPCRs. GPCRs were reported to activate the phospholipase C (PLC)-β3/ inositol 1,4,5-trisphosphate receptor (IP3R)/ Ca

conclusionsCollectively, our findings proved α-hed as a promising candidate for inducing non-apoptotic cell death, paraptosis. It may overcome the resistance of apoptotic-based chemo-resistance in CRC.

Indexed as

CalciumCell ProliferationColorectal NeoplasmsOleanolic AcidParaptosisAnimalsApoptosisCalcium SignalingCell Line, TumorHumansMAP Kinase Signaling SystemMiceMice, Inbred BALB CMice, NudeMolecular Docking SimulationSaponinsbeta-hederinCalciumOleanolic AcidSaponinscalciumcolorectal cancerMAPKparaptosisα‐Hederin

Identifiers

PMID38659391
PMCPMC11043672
OpenAlexW4395455921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.